Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1991 Jan 26;302(6770):203–207. doi: 10.1136/bmj.302.6770.203

Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS.

B S Peters 1, E J Beck 1, D G Coleman 1, M J Wadsworth 1, O McGuinness 1, J R Harris 1, A J Pinching 1
PMCID: PMC1669078  PMID: 1998759

Abstract

OBJECTIVE--To study the changes in morbidity, mortality, and survival patterns in a population of patients with AIDS in the United Kingdom from 1982 to 1989. DESIGN--A retrospective analysis of inpatient and outpatient records of patients with AIDS. SUBJECTS--347 Patients with AIDS, predominantly homosexual or bisexual men. SETTING--Departments of immunology and genitourinary medicine, St Mary's Hospital, London. MAIN OUTCOME MEASURES--Presenting diagnosis of AIDS, occurrence of other opportunist diseases, cause of death, and survival since AIDS was diagnosed, in particular for those patients with Pneumocystis carinii pneumonia or Kaposi's sarcoma. RESULTS--The overall proportion of patients who developed P carinii pneumonia dropped from 56% (20/36) in 1984 to 24% (46/194) in 1989, although it has remained the index diagnosis in about half of new patients. Kaposi's sarcoma has decreased as index diagnosis from 30% (20/67) to 20% (15/74) over the same period, though the prevalence has remained constant at around 35%. P carinii pneumonia accounted for 46% (16/35) of known causes of death in 1986 but only 3% (1/31) in 1989. Conversely, deaths due to Kaposi's sarcoma rose from 14% (1/7) to 32% (10/31) between 1984 and 1989. Lymphoma accounted for an increased proportion of deaths among these patients with 16% (5/31) of deaths in 1989. Their median survival increased from 10 months in 1984-6 to 20 months in 1987. CONCLUSIONS--The changing patterns of disease in patients with AIDS have important implications both for health care provision and future medical research. Medical and nursing provision must be made for the increased morbidity of these diseases and the increased survival of these patients. Research should now be directed towards developing effective treatments for the opportunist infections which are currently more difficult to treat, the secondary malignancies of AIDS, as well as more effective immunorestorative treatments. Future changes in disease patterns must be recognised at an early stage so that resources can be adequately planned and allocated.

Full text

PDF
203

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beral V., Peterman T. A., Berkelman R. L., Jaffe H. W. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet. 1990 Jan 20;335(8682):123–128. doi: 10.1016/0140-6736(90)90001-l. [DOI] [PubMed] [Google Scholar]
  2. Brenner M., Ognibene F. P., Lack E. E., Simmons J. T., Suffredini A. F., Lane H. C., Fauci A. S., Parrillo J. E., Shelhamer J. H., Masur H. Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis. 1987 Nov;136(5):1199–1206. doi: 10.1164/ajrccm/136.5.1199. [DOI] [PubMed] [Google Scholar]
  3. Creagh-Kirk T., Doi P., Andrews E., Nusinoff-Lehrman S., Tilson H., Hoth D., Barry D. W. Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program. JAMA. 1988 Nov 25;260(20):3009–3015. [PubMed] [Google Scholar]
  4. Fischl M. A., Dickinson G. M., La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA. 1988 Feb 26;259(8):1185–1189. doi: 10.1001/jama.259.8.1185. [DOI] [PubMed] [Google Scholar]
  5. Fischl M. A., Richman D. D., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Schooley R. T. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):185–191. doi: 10.1056/NEJM198707233170401. [DOI] [PubMed] [Google Scholar]
  6. Gardner T. D., Youle M., Hanson P. J., Griffiths P. D., Collins J. V., Gazzard B. G. Diagnosis, treatment and outcome of pneumonia in the acquired immune deficiency syndrome. J Infect. 1989 Mar;18(2):111–117. doi: 10.1016/s0163-4453(89)91038-4. [DOI] [PubMed] [Google Scholar]
  7. Harris J. E. Improved short-term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia, 1984 through 1987. JAMA. 1990 Jan 19;263(3):397–401. [PubMed] [Google Scholar]
  8. Leoung G. S., Mills J., Hopewell P. C., Hughes W., Wofsy C. Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med. 1986 Jul;105(1):45–48. doi: 10.7326/0003-4819-105-1-45. [DOI] [PubMed] [Google Scholar]
  9. MacFadden D. K., Edelson J. D., Hyland R. H., Rodriguez C. H., Inouye T., Rebuck A. S. Corticosteroids as adjunctive therapy in treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet. 1987 Jun 27;1(8548):1477–1479. doi: 10.1016/s0140-6736(87)92219-7. [DOI] [PubMed] [Google Scholar]
  10. Penn I. The occurrence of malignant tumors in immunosuppressed states. Prog Allergy. 1986;37:259–300. doi: 10.1159/000318448. [DOI] [PubMed] [Google Scholar]
  11. Peters B. S., Bennett J. M., Jeffries D. J., Knox K., Kocsis A., Pinching A. J. Ineffectiveness of AL721 in HIV disease. Lancet. 1990 Mar 3;335(8688):545–546. doi: 10.1016/0140-6736(90)90782-z. [DOI] [PubMed] [Google Scholar]
  12. Peters B. S., Matthews J., Gompels M., Hartley J. C., Pinching A. J. Acute myeloblastic leukaemia in AIDS. AIDS. 1990 Apr;4(4):367–368. doi: 10.1097/00002030-199004000-00016. [DOI] [PubMed] [Google Scholar]
  13. Rothenberg R., Woelfel M., Stoneburner R., Milberg J., Parker R., Truman B. Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med. 1987 Nov 19;317(21):1297–1302. doi: 10.1056/NEJM198711193172101. [DOI] [PubMed] [Google Scholar]
  14. Selik R. M., Starcher E. T., Curran J. W. Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends. AIDS. 1987 Sep;1(3):175–182. [PubMed] [Google Scholar]
  15. Stambuk D., Youle M., Hawkins D., Farthing C., Shanson D., Farmer R., Lawrence A., Gazzard B. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study. Q J Med. 1989 Feb;70(262):161–174. [PubMed] [Google Scholar]
  16. Swart A. M., Weller I., Darbyshire J. H. Early HIV infection: to treat or not to treat? BMJ. 1990 Oct 13;301(6756):825–826. doi: 10.1136/bmj.301.6756.825. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES